BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.94 USD | +0.45% |
|
+2.16% | -12.41% |
| May. 10 | Bristol-Myers Squibb Says Phase 3 Trial of Opdivo in Lung Cancer Fails to Meet Primary Endpoint | MT |
| May. 10 | Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint | DJ |
2c26cb958b850142fab25.dC6CHCn35lqO3zXIxqr94hUW53fPULIFnnn4gykbxZ4.Lhe1X1uzoG3qpwCwlNyuqF9hshD7KfYz2zHPsG8phv0RYLRwWp2OOfusDQ~10d35372b9424f1f5deb6c09db618c10